Skip to main content

Advertisement

SpringerLink
Log in

Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?

  • Review
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

The corticotropin-releasing factor (CRF) family of neuropeptides is composed of CRF, urocortin 1 (UCN 1), UCN 2 and UCN 3, which can bind to CRF-binding protein (CRF-BP) and two known receptors, CRFR1 and CRFR2, to perform many pathophysiological functions, including inflammation. In contrast to its anti-inflammatory effect in the central nervous system, the roles of the CRF family and its receptors in the periphery are diverse. However, the biological activities of the CRF family in inflammation are circumstantial and remain controversial. It is suggested that this diverse effects of the CRF family may be due to the different types of CRF receptors, different cells and tissues and even different concentrations of CRF family peptides. Though there are difficulties or limitations in establishing the exact modulatory roles of the CRF family and its receptors in peripheral inflammation, the application of CRF receptor agonists or antagonists to treat inflammatory diseases is being pursued with increasing interest. This review describes the effects and mechanisms of the CRF family and its receptors in inflammation; the possible application of CRF receptor agonists or antagonists in inflammatory diseases or disorders will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vale W, Speiss J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–7.

    Article  PubMed  CAS  Google Scholar 

  2. Huising MO, Vaughan JM, Shah SH, Grillot KL, Donaldson CJ, Rivier J, Flik G, Vale WW. Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1. J Biol Chem. 2008;283:8902–12.

    Article  PubMed  CAS  Google Scholar 

  3. Gravanis A, Margioris AN. The corticotrophin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem. 2005;12:1503–12.

    Article  PubMed  CAS  Google Scholar 

  4. Bruijnzeel AW, Gold MS. The role of corticotrophin-releasing factor peptides in cannabis, nicotine, and alcohol dependence. Brain Res Rev. 2005;49:505–28.

    Article  PubMed  CAS  Google Scholar 

  5. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of UCNs in mammals: ancient CRF paralogs. Front Neuroendocrinol. 2007;28:1–27.

    Article  PubMed  CAS  Google Scholar 

  6. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol. 2000;428:191–212.

    Article  PubMed  Google Scholar 

  7. Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, et al. UCN and corticotropinreleasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab. 2001;86:1362–9.

    Article  PubMed  CAS  Google Scholar 

  8. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, et al. Expression of UCN and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab. 2002;87:340–6.

    Article  PubMed  CAS  Google Scholar 

  9. Zmijewski MA, Slominski AT. Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol. 2010;57:1–13.

    PubMed  CAS  Google Scholar 

  10. Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, et al. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA. 2005;102:2620–5.

    Article  PubMed  CAS  Google Scholar 

  11. Lightman SL. The neuroendocrinology of stress: a never ending story. J Neuroendocrinol. 2008;20:880–4.

    Article  PubMed  CAS  Google Scholar 

  12. Cao J, Boucher W, Kempuraj D, Donelan JM, Theoharides TC. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants. J Urol. 2006;176:1208–13.

    Article  PubMed  CAS  Google Scholar 

  13. Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol. 2005;174:7665–75.

    PubMed  CAS  Google Scholar 

  14. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun. 2002;70:6068–74.

    Article  PubMed  CAS  Google Scholar 

  15. Ralph JA, Zocco D, Bresnihan B, Fitzgerald O, McEvoy AN, Murphy EP. A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue. Am J Pathol. 2007;170:1121–33.

    Article  PubMed  CAS  Google Scholar 

  16. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, et al. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab. 2001;86:4344–52.

    Article  PubMed  CAS  Google Scholar 

  17. la Fleur SE, Wick EC, Idumalla PS, Grady EF, Bhargava A. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci USA. 2005;102:7647–52.

    Article  PubMed  CAS  Google Scholar 

  18. Wu Y, Xu Y, Zhou H, Tao J, Li S. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. J Endocrinol. 2006;189:167–78.

    Article  PubMed  CAS  Google Scholar 

  19. Wu Y, Hu J, Zhang R, Zhou C, Xu Y, Guan X, et al. Enhanced intracellular calcium induced by urocortin is involved in degranulation of rat lung mast cells. Cell Physiol Biochem. 2008;21:173–82.

    Article  PubMed  CAS  Google Scholar 

  20. Wu Y, Zhang R, Zhou C, Xu Y, Guan X, Hu J, et al. Enhanced expression of vascular cell adhesion molecule-1 by corticotrophin-releasing hormone contributes to progression of atherosclerosis in LDL receptor-deficient mice. Atherosclerosis. 2009;203:360–70.

    Article  PubMed  CAS  Google Scholar 

  21. Xu Y, Zhang R, Chen J, Zhang Q, Wang J, Hu J, et al. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Br J Pharmacol. 2009;157:1368–79.

    Article  PubMed  CAS  Google Scholar 

  22. Zocco D, McMorrow JP, Murphy EP. Histamine modulation of peripheral CRH receptor type 1alpha expression is dependent on Ca2+ signalling and NF-κB/p65 transcriptional activity. Mol Immunol. 2010;47:1426–37.

    Article  PubMed  CAS  Google Scholar 

  23. Serda SM, Wei ET. Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury. Cryobiology. 1991;28:185–90.

    Article  PubMed  CAS  Google Scholar 

  24. Fleisher-Berkovich S, Rimon G, Danon A. Corticotropin releasing factor modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: receptor binding and effects of antagonists. Regul Pept. 1998;77:121–6.

    Article  PubMed  CAS  Google Scholar 

  25. Bozkurt A, Ghandour S, Okboy N, Oner S, Arbak S, Coşkun T, et al. Inflammatory response to cold injury in remote organs is reduced by corticotropin-releasing factor. Regul Pept. 2001;99:131–9.

    Article  PubMed  CAS  Google Scholar 

  26. Kiang JG, Wei ET. Corticotropin-releasing factor inhibits thermal injury. J Pharmacol Exp Ther. 1987;243:517–20.

    PubMed  CAS  Google Scholar 

  27. Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation. Peptides. 2009;30:365–72.

    Article  PubMed  CAS  Google Scholar 

  28. Kokkotou E, Torres D, Moss AC, O’Brien M, Grigoriadis DE, Karalis K, et al. Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J Immunol. 2006;177:3355–61.

    PubMed  CAS  Google Scholar 

  29. Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J, et al. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2α. Gut. 2007;56:1210–7.

    Article  PubMed  CAS  Google Scholar 

  30. Cureton EL, Ereso AQ, Victorino GP, Curran B, Poole DP, Liao M, et al. Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation. Endocrinology. 2009;150:5428–37.

    Article  PubMed  CAS  Google Scholar 

  31. Zhang R, Xu Y, Fu H, Wang J, Jin L, Li S. Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells. Br J Pharmacol. 2009;158:819–29.

    Article  PubMed  CAS  Google Scholar 

  32. Moffatt JD, Lever R, Page CP. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. FASEB J. 2006;20:1877–9.

    Article  PubMed  CAS  Google Scholar 

  33. Wang MJ, Lin SZ, Kuo JS, Huang HY, Tzeng SF, Liao CH, et al. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol. 2007;179:6204–14.

    PubMed  CAS  Google Scholar 

  34. Torricelli M, Voltolini C, Bloise E, Biliotti G, Giovannelli A, De Bonis M, et al. Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells. Am J Reprod Immunol. 2009;62:224–31.

    Article  PubMed  CAS  Google Scholar 

  35. Tsatsanis C, Androulidaki A, Dermitzaki E, Charalampopoulos I, Spiess J, Gravanis A, et al. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett. 2005;579:4259–64.

    Article  PubMed  CAS  Google Scholar 

  36. Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol. 2007;210:774–83.

    Article  PubMed  CAS  Google Scholar 

  37. Chang J, Hoy JJ, Idumalla PS, Clifton MS, Pecoraro NC, Bhargava A. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides. 2007;28:1453–60.

    Article  PubMed  CAS  Google Scholar 

  38. Szekanecz Z, Koch AE. Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3:635–43.

    Article  PubMed  CAS  Google Scholar 

  39. Arroyo AG, Iruela-Arispe ML. Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res. 2010;86:226–35.

    Article  PubMed  CAS  Google Scholar 

  40. Wakahashi S, Nakabayashi K, Maruo N, Yata A, Ohara N, Maruo T. Effects of corticotropin-releasing hormone and stresscopin on vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts. Endocrine. 2008;33:144–51.

    Article  PubMed  CAS  Google Scholar 

  41. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, et al. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA. 2002;99:7734–9.

    Article  PubMed  CAS  Google Scholar 

  42. Wang J, Xu Y, Xu Y, Zhu H, Zhang R, Zhang G, et al. Urocortin’s inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. Cancer Invest. 2008;26:359–68.

    Article  PubMed  Google Scholar 

  43. Wang J, Jin L, Chen J, Li S. Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells. Cancer Invest. 2010;28:146–55.

    Article  PubMed  CAS  Google Scholar 

  44. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature. 1991;349:423–6.

    Article  PubMed  CAS  Google Scholar 

  45. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA. 1992;89:4192–6.

    Article  PubMed  CAS  Google Scholar 

  46. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol. 1995;16:362–82.

    Article  PubMed  CAS  Google Scholar 

  47. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 2001;15:1678–93.

    Article  PubMed  CAS  Google Scholar 

  48. Woods RJ, Kemp CF, David J, Sumner IG, Lowry PJ. Cleavage of recombinant human corticotropin-releasing factor (CRF)-binding protein produces a 27-kilodalton fragment capable of binding CRF. J Clin Endocrinol Metab. 1999;84:2788–94.

    Article  PubMed  CAS  Google Scholar 

  49. Woods RJ, David J, Baigent S, Gibbins J, Lowry PJ. Elevated levels of corticotrophin-releasing factor binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluid. Br J Rheumatol. 1996;35:120–4.

    Article  PubMed  CAS  Google Scholar 

  50. Florio P, Busacca M, Vignali M, Viganò P, Woods RJ, Lowry PJ, Genazzani AR, Luisi S, Santuz M, Petraglia F. Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women. J Endocrinol Invest. 1998;21:37–42.

    PubMed  CAS  Google Scholar 

  51. Florio P, Woods RJ, Genazzani AR, Lowry PJ, Petraglia F. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF binding protein levels in pregnant women at term and during labor. J Clin Endocrinol Metab. 1997;82:835–8.

    Article  PubMed  CAS  Google Scholar 

  52. Petraglia F, Florio P, Simoncini T, Woods RJ, Giuntini A, Gremigni R, Serra GB, Genazzani AR, Lowry PJ. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Placenta. 1997;18:115–9.

    Article  PubMed  CAS  Google Scholar 

  53. Petraglia F, Florio P, Benedetto C, Gallo C, Woods RJ, Genazzani AR, Lowry PJ. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J Clin Endocrinol Metab. 1996;81:852–6.

    Article  PubMed  CAS  Google Scholar 

  54. Florio P, Romero R, Chaiworapongsa T, Kusanovic JP, Torricelli M, Lowry PJ, Petraglia F. Amniotic fluid and umbilical cord plasma corticotropin-releasing factor (CRF), CRF-binding protein, adrenocorticotropin, and cortisol concentrations in intraamniotic infection and inflammation at term. J Clin Endocrinol Metab. 2008;93:3604–9.

    Article  PubMed  CAS  Google Scholar 

  55. Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, et al. Urocortin 2 infusion in human heart failure. Eur Heart J. 2007;28:2589–97.

    Article  PubMed  CAS  Google Scholar 

  56. Venkatasubramanian S, Newby DE, Lang NN. Urocortins in heart failure. Biochem Pharmacol. 2010;80:289–96.

    Article  PubMed  CAS  Google Scholar 

  57. Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn’s disease. Gut. 2006;55:824–32.

    Article  PubMed  CAS  Google Scholar 

  58. Gonzalez-Rey E, Chorny A, Varela N, O’Valle F, Delgado M. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Arthritis Rheum. 2007;56:531–43.

    Article  PubMed  CAS  Google Scholar 

  59. Saito-Nakaya K, Hasegawa R, Nagura Y, Ito H, Fukudo S. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenterol Motil. 2008;20:1147–56.

    Article  PubMed  CAS  Google Scholar 

  60. Mayer EA, Raybould H, Koelbel C. Neuropeptides, inflammation, and motility. Dig Dis Sci. 1988;33:71S–7S.

    Article  PubMed  CAS  Google Scholar 

  61. Im E, Rhee SH, Park YS, Fiocchi C, Taché Y, Pothoulakis C. Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. Gastroenterology. 2010;138:2457–67.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Natural Science Foundation of China (No. 30772596) and Graduate Student Training and Development Project of Jiangsu Province (CX08B-198Z).

Author information

Authors and Affiliations

  1. Department of Haematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

    Huayuan Zhu & Jianyong Li

  2. Department of Pharmacology, Nanjing Medical University, Nanjing, 210029, China

    Juejin Wang & Shengnan Li

Authors
  1. Huayuan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juejin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianyong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shengnan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shengnan Li.

Additional information

Responsible editor: Kumar Visvanathan.

H. Zhu and J. Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, H., Wang, J., Li, J. et al. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?. Inflamm. Res. 60, 715–721 (2011). https://doi.org/10.1007/s00011-011-0329-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-011-0329-2

Keywords

Search

Navigation